WILLIAM WARE: Open Payments
NPI 1497716849 · ASTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,230 in 199 payments from 31 companies in 2025. Trend: 2023 $3,664 · 2024 $4,002 · 2025 $4,230
Food & beverage: $4,230
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $482 |
| AstraZeneca Pharmaceuticals LP | 16 | $414 |
| ABBVIE INC. | 19 | $406 |
| PFIZER INC. | 24 | $380 |
| GlaxoSmithKline, LLC. | 13 | $294 |
| Otsuka America Pharmaceutical, Inc. | 12 | $229 |
| Lilly USA, LLC | 4 | $180 |
| Braeburn Inc. | 3 | $171 |
| Axsome Therapeutics, Inc. | 7 | $163 |
| Astellas Pharma US Inc | 10 | $148 |
Products named: Wegovy, REXULTI, TRELEGY ELLIPTA, AIRSUPRA, BRIXADI, JARDIANCE, QULIPTA, Auvelity.
Industry payments across PA — which companies pay providers there.
